EUVIMED · CrossrefJournal
ONCOLOGY
ISSN 0890-9091 · MJH Life Sciences
Latest articles
The Next Frontier of Cellular Therapy in Oncology
A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis
Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer
Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City
Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis
Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma
Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance
Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer
Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association
Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?
Before Certainty
Exploring the Influencing Factors of Quality of Life During Maintenance Phase in Patients With Breast Cancer-Related Lymphedema.
Comparison of the 3 Most Commonly Used Modified PD-1 Inhibitors Plus Chemotherapy in Inoperable Wild-Type Non-Small Cell Lung Cancer
Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study
A Multicenter Quality Audit Standardizing Esophageal Contouring in Postmastectomy Radiotherapy.
When the World Stopped: A Lesson in Strength and Second Chances.
Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer
Extranodal NK/T-Cell Lymphoma Misdiagnosed as Pulmonary Infection
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma
Cutaneous T-Cell Lymphoma: Current and Emerging Therapies
Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US
Minority Enrollment to Clinical Trials: Road to Increased Access
Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma
Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor
Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma
The complexity of carcinosarcoma
Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab
A New Horizon in Cancer Care: Liquid Biopsy
EUVIMED